Starling Oncology, Inc. (STLN)
NASDAQ: STLN · Real-Time Price · USD
5.17
+0.04 (0.78%)
At close: Aug 4, 2026, 4:00 PM EDT
5.22
+0.05 (0.97%)
After-hours: Aug 4, 2026, 7:31 PM EDT
Starling Oncology Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Starling Oncology stock has a consensus rating of "Strong Buy" and an average price target of $8.40. The average 1-year stock price forecast is 62.48% higher than the current stock price, while the lowest is $7.00 (+35.40%) and the highest is $10 (+93.42%).
Price Target: $8.40 (+62.48%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Starling Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Maintains $7 | Buy | Maintains | $7 | +35.40% | Aug 3, 2026 |
| BTIG | BTIG | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | +74.08% | Jul 16, 2026 |
| Lake Street | Lake Street | Buy Initiates $10 | Buy | Initiates | $10 | +93.42% | Jul 6, 2026 |
| Noble Financial | Noble Financial | Buy Reiterates $8 | Buy | Reiterates | $8 | +54.74% | May 8, 2026 |
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Reiterates $6 → $8 | Buy | Reiterates | $6 → $8 | +54.74% | Mar 13, 2026 |
Financial Forecast
Revenue This Year
655.54M
from 502.73M
Increased by 30.40%
Revenue Next Year
825.48M
from 655.54M
Increased by 25.92%
EPS This Year
n/a
EPS Next Year
n/a